Vivaldi Coelho Rogerio
- SEC CIK
- 0001610381
In the past year, 2 open-market sale filings worth $300.8K and no purchases.
Current role at each company
- CRNX Crinetics Pharmaceuticals, Inc.Directoras of Sep 1, 2026
- VTRS Viatris IncDirectoras of Mar 10, 2026
- SGTX Sigilon Therapeutics, Inc.PRESIDENT AND CEOas of Aug 11, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $300.8K
- 2 filings
- Net
- −$300.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Vivaldi Coelho Rogerio as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRNX Crinetics Pharmaceuticals, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2023 (view filing) | Jun 8 | 1 day | Vivaldi Coelho RogerioDirector | PPurchase | +5.00K | $22.06 | +$110.3K | New position5.00K after | |
| Mar 13, 2026 (view filing) | Mar 12 | 1 day | Vivaldi Coelho RogerioDirector | SSale | −5.00K | $36.15 | −$180.8K | −23.5%16.3K after | 2 lots10b5-1 |
| Jul 7, 2026 (view filing)4:30 PM ET | Jul 2 | 5 days | Vivaldi Coelho RogerioDirector | SSale | −3.00K | $40.00 | −$120.0K | −13.5%19.2K after | 10b5-1 |